Vortex technology developed by NTU spin-off speeds up cooling while saving energy
4 questions as Airbnb’s IPO looms
These 3 5G Stocks Are Must-Watch Names, Say Top Analysts
So, Where Are We Now?
Tokyo’s voluntary standstill may have stopped COVID-19 in its tracks
Hutchins Roundup: EITC, consumer credit, and more
Social media can guide public pandemic policy: QUT research
Argonne collaborates on largest COVID-19 viral sequence analysis in U.S.
For quick COVID-19 testing, iSCAN can
Pandemic Emergency Jobless Claims Soar To New Record High
How to handle the next lockdown and Christmas – some tips for recently separated parents
World Sees Most Daily COVID-19 Deaths Yet As Greece Imposes National Lockdown:Live Updates
Slow pace of improvement in jobless claims continues
Post-election grief is real, and here are 5 coping strategies – including getting back into politics
Four energy-saving lessons from the first lockdown which may help us through the winter
Even If Biden Wins, President Trump's Agenda Will Endure As Obama-Era Gridlock Returns To Washington
AZ’s Q3 results disappoint – but COVID19 vaccine trial is still on track
Hologic Quarterly Profit Triples On Covid-19 Test Sales; Shares Rise
Berlin Brandenburg Airport Willy Brandt now fully operational
"Remember, Remember, The 5th Of November..."
Biogen Rockets 44% On “Substantial Evidence” For Alzheimer’s Drug Approval
Expedia Gains 6% Despite Third Consecutive Loss
Midwestern States Thrive With Fewer Virus Rules As Second Wave Arrives
Denmark Discovers New COVID-19 Strain That Could Complicate Vaccine Effort: Live Updates
US Sets New Record By Reporting 100k COVID-19 Cases In A Day: Live Updates
Biden Launches Presidential 'Transition Team', Trump Asks SCOTUS To Intervene
NYC first responders have high Covid-19 rates; public surfaces may hold clues to virus spread
Even if you're asymptomatic, COVID-19 can harm your heart, study shows – here's what student athletes need to know
Another COVID-19 'Myth' Busted: Schools Aren't Driving Infection Rates, Study Finds
Novavax, Australia Ink Deal For 40M Covid Vaccine Doses; Shares Rise